Botox & Filler: RN Delegation and Supervision Rules, by State

Whether a registered nurse can inject Botox or dermal filler—and how closely a physician must supervise—changes dramatically the moment you cross a state line. Here is how delegation and supervision rules actually work, and how to structure a program that stays compliant.

Neuromodulators and dermal fillers are prescription medical devices and drugs. That single legal fact is what turns a seemingly simple cash-pay aesthetic service into one of the most heavily regulated corners of medicine. A registered nurse (RN) can be an exceptional injector clinically, but whether that RN may legally inject—and under what level of physician oversight—depends entirely on the state in which the needle touches skin.

This guide walks through the core concepts: who may delegate injectables, what a good faith exam requires, and how supervision models differ across the country. Rules change frequently and vary by state, so treat this as an orientation, not legal advice—always confirm current requirements with qualified healthcare counsel and your state boards of medicine and nursing.

Why state lines matter so much for injectables

Botox, Dysport, and the hyaluronic-acid fillers are all prescription products. Prescribing is the practice of medicine, reserved for licensed physicians (and, depending on the state and their own scope, nurse practitioners and physician assistants). An RN does not independently prescribe. Instead, an RN administers a treatment that a qualified prescriber has ordered for a specific patient after a valid examination.

Three separate regulatory layers stack on top of each other, and each can differ by state:

• The Medical Practice Act—who may diagnose, prescribe, and delegate medical acts.
• The Nurse Practice Act—what an RN may accept by delegation and perform within scope.
• The Corporate Practice of Medicine (CPOM) doctrine—who may own and control the clinical entity that bills for and delivers care.

Because these layers interact differently in each jurisdiction, a model that is fully compliant in one state can be unlawful next door.

Who can delegate Botox and filler injections?

Delegation flows from a prescriber. The prescriber evaluates the patient, determines that an injectable is appropriate, and issues an order. Only then may an RN administer it. The prescriber is almost always a physician serving as medical director, or an NP/PA operating within their own authorized scope.

The good faith exam is non-negotiable

Nearly every state requires a good faith examination (GFE) establishing a bona fide provider-patient relationship before any prescription-strength injectable is ordered. The GFE includes a relevant history, an assessment of the treatment area, and a determination that the treatment is appropriate for that specific patient. An RN generally cannot perform the GFE, because doing so would amount to diagnosing and prescribing.

States differ on whether the GFE may be conducted via telehealth, whether it can precede the visit, and how often it must be repeated for established patients. Some boards have issued explicit guidance that a synchronous audio-video GFE is acceptable; others insist on an in-person evaluation for the initial visit. This is one of the most actively enforced requirements in aesthetic medicine.

Standing orders versus direct supervision

Once a valid order exists, the supervision question becomes: how physically present must the supervising prescriber be while the RN injects?

• Direct (on-site) supervision—the prescriber must be physically present in the facility and immediately available.
• Indirect or general supervision—the prescriber must be reachable (often by phone) and available to respond, but need not be on-site.
• Standing-order / protocol models—patient-specific orders issued after a GFE allow the RN to administer within a written protocol, with the prescriber available per state rules.

Supervision models by state type

States tend to cluster into a few patterns. The labels below are simplifications—confirm the specifics for any state where you operate.

Stricter, physician-forward states

Some states require a physician (not an NP or PA) to perform or closely oversee the GFE, mandate on-site or readily available physician supervision, and limit who may delegate. States in this group have historically included California, Florida, New York, New Jersey, and Texas, each with its own nuances—for example, California's strong CPOM enforcement and Florida's electronic-prescribing and registration rules.

Moderate, delegation-friendly states

Many states permit an RN to inject under a prescriber's order with indirect supervision, provided a proper GFE and protocols are in place. The prescriber must be available but need not stand beside the RN. Arizona, Colorado, and Georgia are often cited examples, though requirements still apply.

States with explicit board guidance

A growing number of nursing and medical boards have published aesthetic-specific position statements clarifying that injectables require a prescriber order, a GFE, and emergency protocols (including on-site access to reversal agents like hyaluronidase). Where such guidance exists, follow it precisely.

The recurring enforcement theme across states is not the injection itself—it is the missing examination, the absent order, and the unclear line of clinical authority behind the needle.

Building a compliant injectables program with a PC and MSO

If you operate a med spa, gym, salon, or 503A compounding pharmacy and want to offer medical-grade aesthetics under your own brand, the structure matters as much as the clinical protocol. In CPOM states, the clinical entity must be a physician-owned professional corporation (PC). The physician retains full clinical authority—hiring and supervising clinical staff, owning the GFE and ordering process, and making every medical decision.

A separate management services organization (MSO) handles the non-clinical side: scheduling software, marketing, real estate, equipment, billing operations, and administrative staffing. The MSO supports the practice; it does not practice medicine, employ the physicians' clinical judgment, or own the clinical entity. Compensation between the parties is structured as a flat, fair-market-value management fee—never a percentage of clinical revenue and never a per-prescription or per-treatment payment, both of which raise anti-kickback and fee-splitting concerns.

This is the model MDside operates. We connect aesthetic businesses to a nationwide physician network of medical directors who provide the licensed clinical layer—GFEs, orders, supervision, and protocols—while your brand stays front and center. We never structure compensation around referrals or revenue share, and we are transparent about how patient data is handled; you can review our Security & Trust practices for the details.

A practical compliance checklist

Before your first RN injection in any state, confirm each of the following with counsel:

• Prescriber and delegation: Is the supervising physician (or authorized NP/PA) properly credentialed and permitted to delegate in this state?
• Good faith exam: Who performs it, in person or via telehealth, and how often must it be repeated?
• Supervision level: Does the state require on-site presence, or is availability by phone sufficient?
• Standing orders and protocols: Are patient-specific orders and written emergency protocols (including hyaluronidase access) documented?
• Entity structure: Is the clinical entity a physician-owned PC, with a clean management agreement and a flat, fair-market-value fee?
• Scope of practice: Does the RN's training, and the specific act, fall within the state Nurse Practice Act?
• Documentation: Can you produce the GFE, the order, and the supervision arrangement on demand?

Getting injectables right is less about any single rule and more about building a defensible chain from examination to order to administration, inside a structure that keeps clinical authority where the law requires it. If you want help mapping these requirements to the states you plan to operate in, book a discovery call and we will walk through your specific situation. Because requirements shift and enforcement priorities evolve, pair any plan with current advice from qualified healthcare counsel in each state.